Inhibitor Therapeutics INTI
OTC INTI
$0.11 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Inhibitor Therapeutics (INTI) Short term Debt (2025 - 2026)

Updated

Inhibitor Therapeutics (INTI) recorded Short term Debt of $26,262 in Q2 2026, up 1.1% from $25,987 a year earlier but down 9.4% from the prior quarter.

Analysis

Inhibitor Therapeutics (INTI) Short term Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Inhibitor Therapeutics reported Short term Debt of $24,724.

  • Quarterly Short term Debt has ranged from $24,724 in Q4 2025 to $28,981 in Q1 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $28,981 (Q1 2026), $24,724 (Q4 2025) and $27,455 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.23 Bn 1,139.82 Bn 19.71 Bn
2 Johnson & Johnson 648.76 Bn 568.62 Bn 17.30 Bn
3 AbbVie 503.78 Bn 476.89 Bn 12.70 Bn
4 Merck 366.20 Bn 320.58 Bn 12.21 Bn
5 Novartis Ag 303.55 Bn 267.54 Bn 11.24 Bn
6 Astrazeneca 269.42 Bn 243.11 Bn 12.86 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn
10 Inhibitor Therapeutics 19.12 Mn 11.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26,262.00
Mar 31, 2026 28,981.00
Dec 31, 2025 24,724.00
Sep 30, 2025 27,455.00
Jun 30, 2025 25,987.00
Mar 31, 2025 25,987.00
API Access

Inhibitor Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=INTI&period=max&api_key=YOUR_API_KEY